{"abstract": "Similar drugs targeting the hormone known as insulinlike growth factor 1 had earlier proved disappointing.", "web_url": "https://www.nytimes.com/2012/08/10/business/amgen-citing-weak-results-halts-study-of-pancreatic-cancer-drug.html", "snippet": "Similar drugs targeting the hormone known as insulinlike growth factor 1 had earlier proved disappointing.", "lead_paragraph": "Amgen is halting a late-stage clinical trial of an experimental drug for pancreatic cancer after an outside monitoring panel concluded that the drug was unlikely to improve the survival of patients with an advanced form of the disease.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amgen, Citing Weak Results, Halts Study of a Cancer Drug", "kicker": null, "content_kicker": null, "print_headline": "Amgen, Citing Weak Results, Halts Study of a Cancer Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Clinical Trials", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Pancreatic Cancer", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 4, "major": "N"}], "pub_date": "2012-08-09T23:38:22+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/087d2498-bf59-5e4f-b38b-d1d933169de7", "word_count": 482, "uri": "nyt://article/087d2498-bf59-5e4f-b38b-d1d933169de7"}